Sean  Mcclain net worth and biography

Sean Mcclain Biography and Net Worth

Insider of Absci
Mr. McClain is our Founder and has served as our Chief Executive Officer since August 2011 and a member of our board of directors since the formation of Absci Corporation in October 2020, and a managing member of its predecessor, AbSci LLC, since inception. Mr. McClain also serves as a board member for the Oregon Bioscience Association, Oregon Bioscience Incubator and Oregon Translational Research and Development Institute (OTRADI), and Life Science Washington. Mr. McClain holds a Bachelor of Science degree in Molecular and Cellular Biology in 2011 from the University of Arizona.

What is Sean Mcclain's net worth?

The estimated net worth of Sean Mcclain is at least $19.02 million as of July 26th, 2021. Mr. Mcclain owns 6,361,800 shares of Absci stock worth more than $19,021,782 as of December 21st. This net worth estimate does not reflect any other investments that Mr. Mcclain may own. Learn More about Sean Mcclain's net worth.

How do I contact Sean Mcclain?

The corporate mailing address for Mr. Mcclain and other Absci executives is , , . Absci can also be reached via phone at 360-949-1041 and via email at [email protected]. Learn More on Sean Mcclain's contact information.

Has Sean Mcclain been buying or selling shares of Absci?

Sean Mcclain has not been actively trading shares of Absci during the past quarter. Most recently, on Wednesday, January 19th, Sean Mcclain bought 7,155 shares of Absci stock. The stock was acquired at an average cost of $6.92 per share, with a total value of $49,512.60. Learn More on Sean Mcclain's trading history.

Who are Absci's active insiders?

Absci's insider roster includes Todd Bedrick (VP), Sarah Korman (General Counsel), Sean Mcclain (Insider), and Karen Mcginnis (Director). Learn More on Absci's active insiders.

Are insiders buying or selling shares of Absci?

In the last year, Absci insiders bought shares 1 times. They purchased a total of 222,222 shares worth more than $999,999.00. In the last year, insiders at the sold shares 2 times. They sold a total of 3,119,859 shares worth more than $13,738,897.82. The most recent insider tranaction occured on June, 13th when CFO Zachariah Jonasson sold 19,859 shares worth more than $98,897.82. Insiders at Absci own 9.8% of the company. Learn More about insider trades at Absci.

Information on this page was last updated on 6/13/2024.

Sean Mcclain Insider Trading History at Absci

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/19/2022Buy7,155$6.92$49,512.60View SEC Filing Icon  
7/26/2021Buy600$16.00$9,600.006,361,800View SEC Filing Icon  
See Full Table

Sean Mcclain Buying and Selling Activity at Absci

This chart shows Sean Mcclain's buying and selling at Absci by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Absci Company Overview

Absci logo
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Read More

Today's Range

Now: $2.99
Low: $2.86
High: $3.09

50 Day Range

MA: $3.53
Low: $2.55
High: $4.38

2 Week Range

Now: $2.99
Low: $2.45
High: $6.72

Volume

2,501,115 shs

Average Volume

1,430,013 shs

Market Capitalization

$343.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.02